Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
Serafini, A N
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology May 1998 - 1777-87 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study
0732-183X
10.1200/JCO.1998.16.5.1777 doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--adverse effects
Colorectal Neoplasms--diagnostic imaging
Humans
Middle Aged
Neoplasm Metastasis--diagnostic imaging
Neoplasm Recurrence, Local--diagnostic imaging
Radioimmunodetection
Sensitivity and Specificity
Technetium--adverse effects
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology May 1998 - 1777-87 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study
0732-183X
10.1200/JCO.1998.16.5.1777 doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--adverse effects
Colorectal Neoplasms--diagnostic imaging
Humans
Middle Aged
Neoplasm Metastasis--diagnostic imaging
Neoplasm Recurrence, Local--diagnostic imaging
Radioimmunodetection
Sensitivity and Specificity
Technetium--adverse effects
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed